Browse > Article
http://dx.doi.org/10.15324/kjcls.2019.51.2.221

Can Hinokitiol Kill Cancer Cells? Alternative Therapeutic Anticancer Agent via Autophagy and Apoptosis  

Lee, Tae Bok (Confocal Core Facility, Center for Medical Innovation, Seoul National University Hospital)
Jun, Jin Hyun (Department of Senior Healthcare, BK21 Plus Program, Graduate School of Eulji University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.51, no.2, 2019 , pp. 221-234 More about this Journal
Abstract
Cancer is genetically, metabolically and infectiously induced life threatening disorder showing aggressive growing pattern with invasive tendency. In order to prevent this global menace from jeopardizing human life, enormous studies on carcinogenesis and treatment for chemotherapy resistance have been intensively researched. Hinokitiol (${\beta}$-thujaplicin) extracted from heart wood of cupressaceous is a well-known bioactive compound demonstrating anti-inflammation, anti-bacteria and anti-cancer effects on several cancer types via apoptosis and autophagy. This study proposed that hinokitiol activates transcription factor EB (TFEB) nuclear translocation for autophagy and lysosomal biogenesis regardless of nutrient condition in cancer cells. Mitophagy and ${\beta}$-catenin translocation into the nucleus under treatment of hinokitiol on non-small cell lung cancer (NSCLC) cells and HeLa cells were investigated. Hinokitiol exerted cytotoxicity on HeLa and HCC827 cells; moreover, artificially induced autophagy by overexpression of TFEB granted imperfect sustainability onto HeLa cells. Taken together, hinokitiol is the prominent autophagy inducer and activator of TFEB nuclear translocation. Alternative cancer therapy via autophagy is pros and cons since the autophagy in cancer cells is related to prevention and survival mechanism depending on nutrition. To avoid paradox of autophagy in cancer therapy, fine-tuned regulation and application of hinokitiol in due course for successful suppressing cancer cells are recommended.
Keywords
Autophagy; Cancer; Hinokitiol (${\beta}$-thujaplicin); Non-small cell lung cancer (NSCLC); Transcription factor EB (TFEB);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Martini-Stoica H, Xu Y, Ballabio A, Zheng H. The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 2016;39:221-234. https://doi.org/10.1016/j.tins.2016.02.0002.   DOI
2 Zhang J, Wang J, Wu J, Lu Y, Jiang J, Wang L, et al. Curcumin targets the TFEB-lysosome pathway for induction of autophagy. Oncotarget. 2016;75659-75671. https://doi.org/10.18632/oncotarget.12318.   DOI
3 Song JX, Sun YR, Peluso I, Zeng Y, Yu X, Lu JH, et al. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy. 2016;12: 1372-1389. https://doi.org/10.1080/15548627.2016.1179404.   DOI
4 Jayakumar T, Liu CH, Wu GY, Lee TY, Manubolu M, Hsieh CY, at al. Hinokitiol inhibits migration of A549 lung cancer cells via suppression of MMPs and induction of antioxidant enzymes and apoptosis. Int J Mol Sci. 2018;19:E939. https://doi.org/10.3390/ijms19040939.   DOI
5 Ouyang WC, Liao YW, Chen PN, Lu KH, Yu CC, Hsieh PL. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation. Cancer Chemother Pharmacol. 2017;80:411-419. https://doi.org/10.1007/s00280- 017-3381-y.   DOI
6 Huang CH, Jayakumar T, Chang CC, Fong TH, Lu SH, Thomas PA, et al. Hinokitiol exerts anticancer activity through downregulation of MMPs 9/2 and enhancement of catalase and SOD enzymes: in vivo augmentation of lung histoarchitecture. Molecules. 2015;20:17720-17734. https://doi.org/10.3390/molecules201017720.   DOI
7 Li LH, Wu P, Lee JY, Li PR, Hsieh WY, Ho CC, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS One. 2014;9:E104203. https://doi.org/10.1371/journal.pone.0104203.   DOI
8 Ouyang L, Luo Y, Tian M, Zhang SY, Lu R, Wang JH, et al. Plant natural products: from traditional compounds to new emerging drugs in cancer therapy. Cell Prolif. 2014;47:506-515. https://doi.org/10.1111/cpr.12143.   DOI
9 Tsao YT, Huang YF, Kuo CY, Lin YC, Chiang WC, Wang WK, et al. Hinokitiol inhibits melanogenesis via AKT/mTOR signaling in B16F10 mouse melanoma cells. Int J Mol Sci. 2016;17:248. https://doi.org/10.3390/ijms17020248.   DOI
10 Napolitano G, Ballabio A. TFEB at a glance. J Cell Sci. 2016;129:2475-2481. https://doi.org/10.1242/jcs.146365.   DOI
11 Lee JH, Jeong JK, Park SY. AMPK activation mediated by hinokitiol inhibits adipogenic differentiation of mesenchymal stem cells through autophagy flux. Int J Endocrinol. 2018;2018: E2014192. https://doi.org/10.1155/2018/2014192.
12 Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 2011;333:1109-1112. https://doi.org/10.1126/science.1201940.   DOI
13 Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10:E12. https://doi.org/10.1186/1476-4598-10-12.   DOI
14 Wu WK, Coffelt SB, Cho CH, Wang XJ, Lee CW, Chan FK, et al. The autophagic paradox in cancer therapy. Oncogene. 2012; 31:939-953. https://doi.org/10.1038/onc.2011.295.   DOI
15 Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23:2891-2906.   DOI
16 Gomes LC, Di Benedetto G, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol. 2011;13:589-598. https://doi.org/10.1038/ncb2220.   DOI
17 Tagaya M, Arasaki K. Regulation of mitochondrial dynamics and autophagy by the mitochondria-associated membrane. Adv Exp Med Biol. 2017;997:33-47. https://doi.org/10.1007/978-981-10-4567-7_3.   DOI
18 Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20:1013-1022. https://doi.org/10.1038/s41556-018-0176-2.   DOI
19 Wilfinger N, Austin S, Scheiber-Mojdekhar B, Berger W, Reipert S, Praschberger M, at al. Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy. Oncotarget. 2016;7:1242-1261. https://doi.org/10.18632/oncotarget.6233.   DOI
20 Gkikas I, Palikaras K, Tavernarakis N. The role of mitophagy in innate immunity. Front Immunol. 2018;9:E1283. https://doi.org/10.3389/fimmu.2018.01283.   DOI
21 Lipinski MM, Zheng B, Lu T, Yan ZY, Py BF, Ng A, et al. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci USA. 2010;107:14164-14169. https://doi.org/10.1073/pnas.1009485107.   DOI
22 Madeo F, Tavernarakis N, Kroemer G. Can autophagy promote longevity? Nat Cell Biol. 2010;12:842-846. https://doi.org/10.1038/ncb0910-842.   DOI
23 Kim W, Kim M, Jho EH. Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem J. 2013;450:9-21. https://doi.org/10.1042/BJ20121284.   DOI
24 Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192-1205. https://doi.org/10.1016/j.cell.2012.05.012.   DOI
25 MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9-26. https://doi.org/10.1016/j.devcel.2009.06.016.   DOI
26 Yoshida T, Sopko NA, Kates M, Liu X, Joice G, McConkey DJ, et al. Three dimensional organoid culture reveals involvement of Wnt b catenin pathway in proliferation of bladder cancer cells. Oncotarget. 2018;9:11060-11070. https://doi.org/10.18632/oncotarget.24308.   DOI
27 Rayan A, Raiyn J, Falah M. Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. Plos One. 2017;12:E0187925. https://doi.org/10.1371/journal.pone.0187925.   DOI
28 Thorburn A, Thamm DH, Gustafson DL. Autophagy and cancer therapy. Mol Pharmacol. 2014;85:830-838. https://doi.org/10.1124/mol.114.091850.   DOI
29 Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012; 45:487-498. https://doi.org/10.1111/j.1365-2184.2012.00845.x.   DOI
30 Lee TB, Seo EJ, Lee JY, Jun JH. Synergistic anticancer effects of curcumin and hinokitiol on gefitinib resistant non-small cell lung cancer cells. Nat Prod Commun. 2018;13:1667-1671. https://doi.org/10.1177/1934578X1801301223.
31 Gao C, Cao WP, Bao L, Zuo W, Xie G, Cai T, et al. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol. 2010;12:781-790. https://doi.org/10.1038/ncb2082.   DOI
32 Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461-1473. https://doi.org/10.1038/onc.2016.304.   DOI
33 Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728-741. https://doi.org/10.1016/j.cell.2011.10.026.   DOI
34 Wang WK, Lin ST, Chang WW, Liu LW, Li TY, Kuo CY, et al. Hinokitiol induces autophagy in murine breast and colorectal cancer cells. Environ Toxicol. 2016;31:77-84. https://doi.org/10.1002/tox.22023.   DOI
35 Saniewski M, Horbowicz M, Kanlayanarat S. The biological activities of troponoids and their use in agriculture a review. J Hortic Res. 2014;22:5-19. https://doi.org/10.2478/johr-2014- 0001.
36 Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221:3-12. https://doi.org/10.1002/path.2697.   DOI
37 Mizushima N. Autophagy: process and function. Genes Dev. 2007;21:2861-2873.   DOI
38 Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hishoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672-676.   DOI
39 Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332:1429-1433. https://doi.org/10.1126/science.1204592.   DOI
40 Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23:2891-2906.   DOI